Atypical Pantothenate Kinase-Associated Neurodegeneration (PKAN)

Welcome to the PKAN Road Map

Looking for the PKAN My Med Team Social Network?

This page does not yet have a sponsor.

Interested in becoming one?  Email us at sponsor@mycitymed.com to learn more.

This page does not yet have a sponsor.

Interested in becoming one?  Email us at sponsor@mycitymed.com to learn more.

This page does not yet have a sponsor.

Interested in becoming one?  Email us at sponsor@mycitymed.com to learn more.

FDA Approves Radicava (edaravone) to Treat ALS

Regenerative Neurobiology

ALS Treatment Updates

 

Showing listings 1-9 of 4328

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

ALS Groups

 

This page does not yet have a sponsor.

Interested in becoming one?  Email us at sponsor@mycitymed.com to learn more.

Featured

View all

PKAN Updates

  • TSX Venture Exchange Stock Maintenance Bulletins 24 Feb 2021 08:58 Tradingcharts.com VANCOUVER, BC, Feb. 22, 2021 (Canada NewsWire via COMTEX) -- TSX VENTURE COMPANIES ALPHA LITHIUM CORPORATION ("ALLI") (ALLI.WT)BULLETIN TYPE: Prospectus - Unit Offering, New Listing-WarrantsBULLETIN DATE: February 22, 2021TSX Venture Tier 2 …
  • PureK Virtually Opens The Market 12 Feb 2021 12:58 Tradingcharts.com TORONTO, Feb. 11, 2021 (Canada NewsWire via COMTEX) -- Kathy Casey, Chief Executive Officer, PureK Holdings Corp. (TSXV: PKAN) (or the "Company"), and her team joined Arne Gulstene, Head, Company Services, TMX Group, to celebrate the Company' …
  • The Week In Cannabis: Stocks Up By Double-Digits On Jazz Pharma's GWPH Acquisition, Potential Federal Moves 06 Feb 2021 03:04 Benzinga Cannabis stocks had one of their strongest weeks in history. Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) acquired GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) for $7.2 billion, or $6.7 billion excluding GW Pharma's cash. The price of $220 per ADS in cash and …
  • CBD Consumer Products Company PureK To Acquire Skincare Brand No B.S. Life 01 Feb 2021 20:41 Benzinga PureK Holdings Corp‎. (TSX:PKAN) is taking over skincare and beauty company No B.S. Life LLC. Under the deal, the Vancouver-based company agreed to pay $500,000 in cash, plus a refundable deposit in the amount of $1.5 million. PureK will pay an additional …
  • The Week In Cannabis: Stocks Spike By Double Digits On Earnings, Strong Sales, Financings 16 Jan 2021 15:07 Benzinga Cannabis stocks widely outperformed the markets after a slew of financing deals and strong earnings reports. “The cannabis industry is off to a great start this year with New York state pushing hard for legalization," Green Market Report editor-in- …
  • Retrophin Inc Shares Up 35.9% Since SmarTrend's Buy Recommendation (RTRX) 12 Jan 2021 07:00 Tradingcharts.com Jan 12, 2021 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Retrophin Inc (NASDAQ:RTRX) on October 6th, 2020 at $20.36. In approximately 3 months, Retrophin Inc has returned 35.89% as of today's recent price of $27.66. …
  • PureK To Acquire BudaPets All-Natural Pet Wellness Brand 11 Jan 2021 17:50 Benzinga PureK Holdings Corp‎. (TSXV:PKAN) plans to acquire the BudaPets brand. The Vancouver company will purchase Nirvana Group LLC, a Florida-based producer and distributor of all-natural pet wellness products.  Under the deal, PureK agreed to issue $1.5 million …
  • Jeff Yauck Announces Filing of Early Warning Report Related to Disposition of Common Shares of PureK Holdings Corp. 31 Dec 2020 23:29 GuruFocus.com VANCOUVER, British Columbia, Dec. 31, 2020 (GLOBE NEWSWIRE) -- On December 29, 2020, Jeff Yauck (the "Acquiror"), with an address care of PureK Holdings Corp. located at ‎6710 N Scottsdale Road‎, Paradise Valley, Arizona, 85253‎ United States, …
  • PureK Holdings Corp. Announces Completion of Qualifying Transaction 08 Dec 2020 22:18 GlobeNewswire, Inc. PHOENIX, Dec. 08, 2020 (GLOBE NEWSWIRE) -- PureK Holdings Corp‎. (the "Company") (TSX Venture: PKAN), formerly AF1 Capital Corp., is pleased to announce that it has completed its previously announced qualifying transaction (the “Qualifying …
  • Uptrend Call Working As Retrophin Inc Stock Rises 17.7% (RTRX) 23 Nov 2020 19:22 Tradingcharts.com Nov 23, 2020 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Retrophin Inc (NASDAQ:RTRX) on October 8th, 2020 at $20.95. In approximately 2 months, Retrophin Inc has returned 17.71% as of today's recent price of $24.66. Over …
  • Mitochondria control cells using their own complete fatty acid synthesis machine 31 Aug 2020 11:49 Phys.org It shouldn't be any secret that mitochondria can make their own fatty acids. The enzymes mitochondria use to do it were discovered decades ago. Unfortunately, only a few individuals among the biologically literate masses have come to appreciate this …
  • 45.2% Return Seen to Date on SmarTrend Retrophin Inc Call (RTRX) 17 Jul 2020 20:07 Tradingcharts.com Jul 17, 2020 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Retrophin Inc (NASDAQ:RTRX) on March 26th, 2020 at $14.13. In approximately 4 months, Retrophin Inc has returned 45.20% as of today's recent price of $20.51. In the …
  • Life-saving medicine finally arrives for Morgan County girl 08 Feb 2020 01:10 WTHR MORGAN COUNTY, Ind. (WTHR) - Nick Cragen and his little girl Amelia are waiting for a small package to arrive that promises to have a huge impact on their lives. “Heaven in a box,” Nick called it, the promised cure for a rare disease that is killing his …
  • God-powered fight against PKAN 06 Feb 2020 02:58 McClusky Gazette - North Dakota By ALLAN TINKER The Kulsrud boys and their parents, grandparents and friends have been following the positive battle the family has made against the neurological condition that has challenged the family. Laura Kulsrud offered their story for us this week. …
  • 5 Beaten-Down Biotech Stocks Set To Rebound In 2020 18 Dec 2019 14:46 Investing.com The Zacks Medical-Biomedical and Genetics industry is up 8.6% this year so far compared with the S&P 500’s increase of 26.1%. The industry includes large as well as small biotech companies, which are much riskier investment bets than drug companies …
  • Retrophin Reports Third Quarter 2019 Financial Results 30 Oct 2019 20:01 GlobeNewswire, Inc. Enrollment on-track in pivotal Phase 3 clinical trials to support registration of sparsentan for patients with FSGS and IgAN Third quarter revenues rose nine percent to $44 million SAN DIEGO, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) …
  • Retrophin: Thesis Falls Back To Sparsentan 15 Oct 2019 04:06 Seeking Alpha 2019 was not kind to Retrophin (RTRX). The company made little progress on the commercial front, though it got the new version of Thiola approved by the FDA, and that’s about it on the good news front. On the negative side, the company decided to pass on …
  • Daron Jessop 12 Oct 2019 10:56 St. George News - Utah March 9, 2008 – October 9, 2019 Our beautiful son, Daron Jessop, age 11, passed away in his mother’s arms on October 9, 2019 after a long and courageous battle with PKAN. Daron was born on March 9, 2008 in St. George, Utah, to Noreen Zitting Jessop and …
  • Yayasan Sabah conducts furniture making course 09 Oct 2019 01:44 Borneo Post Loretto with participants of the furniture making course. KENINGAU: Yayasan Sabah Group through Pusat Kraftangan Sabah (PKS) collaborated with Wood Industry Skills Development Centre (WISDEC) under the Malaysian Timber Industry Board of the Ministry of …
  • Shares of RTRX Down 34.9% Since Downtrend Call on Shares 03 Sep 2019 06:01 Tradingcharts.com Sep 03, 2019 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified a Downtrend for Retrophin Inc (NASDAQ:RTRX) on August 2nd, 2019 at $19.35. In approximately 1 month, Retrophin Inc has returned 34.94% as of today's recent price of $12.59. In the …

This page does not yet have a sponsor.

Interested in becoming one?  Email us at sponsor@mycitymed.com to learn more.

[google_news query=’als’ topic=snc topic=t topic=b topic=s topic=m]

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

©2017 My City Med. All Rights Reserved.

or

Log in with your credentials

or    

Forgot your details?

or

Create Account